29 results
424B5
VERV
Verve Therapeutics Inc
29 Nov 23
Prospectus supplement for primary offering
4:47pm
and interest rates, on our business, operations, strategy and goals.
We may not actually achieve the plans, intentions or expectations disclosed
424B5
pbu8rk
28 Nov 23
Prospectus supplement for primary offering
4:25pm
DEF 14A
o7f6rl
29 Apr 22
Definitive proxy
7:01am
10-K
0fwg8er z7
14 Mar 22
Annual report
7:04am
8-K
EX-99.1
amd1hm
14 Mar 22
Verve Therapeutics Announces Pipeline Progress and Reports Fourth Quarter and Full Year 2021 Financial Results
6:49am
10-Q
znrtp
12 Aug 21
Quarterly report
8:53am
424B4
3mzack4z9hh
17 Jun 21
Prospectus supplement with pricing info
4:50pm